Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
Authors
Keywords
-
Journal
Therapeutics and Clinical Risk Management
Volume Volume 16, Issue -, Pages 749-758
Publisher
Informa UK Limited
Online
2020-08-14
DOI
10.2147/tcrm.s185677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy
- (2020) Dhruv S. Kazi et al. CIRCULATION
- Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
- (2020) David Adams et al. JOURNAL OF NEUROLOGY
- Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
- (2019) Merrill D. Benson et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis
- (2019) Scott D. Solomon et al. CIRCULATION
- Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates
- (2019) Maja M Janas et al. NUCLEIC ACIDS RESEARCH
- Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
- (2019) Mathew S. Maurer et al. Circulation-Heart Failure
- Inotersen therapy of transthyretin amyloid cardiomyopathy
- (2019) Noel R. Dasgupta et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Aortic Stenosis and Cardiac Amyloidosis
- (2019) Julien Ternacle et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart transplantation in cardiac amyloidosis
- (2017) Matthew Sousa et al. HEART FAILURE REVIEWS
- Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
- (2015) Esther González-López et al. EUROPEAN HEART JOURNAL
- Liver transplantation in transthyretin amyloidosis: Issues and challenges
- (2015) Andreia Carvalho et al. LIVER TRANSPLANTATION
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
- (2012) T. Coelho et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started